Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript

(terbinafine hydrochloride)
This medicine is known by any of the above names but will be referred to as Lamisil Tablets
throughout this leaflet.
What you need to know about Lamisil Tablets
Your doctor has decided that you need this medicine to help treat your condition.
Please read this leaflet carefully before you start to take your medicine. It contains
important information. Keep the leaflet in a safe place because you may want to read it
If you have any other questions, or if there is something you don’t understand, please ask
your doctor or pharmacist.
This medicine has been prescribed for you. Never give it to someone else. It may not be the
right medicine for them even if their symptoms seem to be the same as yours.
If any side effects get serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.
In this leaflet:
1. What Lamisil Tablets are, and what they are used for
2. Things to consider before you start to take Lamisil Tablets
3. How to take Lamisil Tablets
4. Possible side effects
5. How to store Lamisil Tablets
6. Further information
Terbinafine, the active ingredient in Lamisil Tablets, is an antifungal medicine.
Lamisil Tablets are used to treat a number of fungal infections of the skin and nails.
Some people MUST NOT take Lamisil Tablets.
Talk to your doctor if:
• you think you may be allergic to terbinafine or to any of the other ingredients of Lamisil
Tablets. (These are listed in Section 6.)
• you have or have had any liver problems
• you are breast-feeding
You should also ask yourself these questions before taking Lamisil Tablets. If the
answer to any of these questions is YES, tell your doctor or pharmacist because Lamisil
Tablets might not be the right medicine for you.
• Are you pregnant or trying to become pregnant?
• Do you have any problems with your kidneys or liver?
• Do you have psoriasis?
• Do you have systemic lupus erythematosis (SLE)?
• Do you have rash due to a high level of a specific type of white blood cells?
Children should not normally be given Lamisil Tablets.
Are you taking other medicines?
Some medicines can interfere with your treatment. Tell your doctor if you are taking any of
the following:
• Rifampicin for infections
• Cimetidine for gastric problems such as indigestion or ulcer
• Antidepressants including tricyclic antidepressants, SSRIs (selective serotonin reuptake
inhibitors), or MAOIs (monoamine oxidase inhibitors)
• Oral contraceptives (as irregular periods and breakthrough bleeding may occur in some
female patients)
• Beta-blockers or anti-arrhythmics for heart problems
• Warfarin, a medicine used to thin your blood
• Medicines to treat heart problems (e.g. propafenone, amiodarone)
• Ciclosporin, a medicine used to control your body’s immune system in order to prevent
rejection of transplanted organs
• Medicines used to treat fungal infections (e.g. fluconazole, ketoconazole)
• Medicines used to treat cough (e.g. dextromethorphan)
• Caffeine
Always tell your doctor about all the medicines you are taking. This means medicines you
have bought yourself as well as medicines on prescription from your doctor.
You should have blood tests before and during treatment with Lamisil Tablets to monitor
your liver function.
Will there be any problems with driving or using machinery?
Some people have reported feeling dizzy or giddy while they are taking Lamisil Tablets.
If you feel like this you should not drive or operate machinery.
The doctor will decide what dose of Lamisil Tablets you should take. Always take the tablets
exactly as your doctor has told you to. The dose will be on the pharmacist’s label. Check the
label carefully. It should tell you how many tablets to take, and how often. If you are not
sure, ask your doctor or pharmacist. Keep taking the tablets for as long as you have been
told unless you have any problems. In that case, check with your doctor.
The usual dose for adults, including the elderly, is 250 mg once a day.
• For skin infections continue taking the tablets for 2 to 6 weeks.
• For nail infections treatment usually lasts for between 6 weeks and 3 months, although
some patients with toenail infections may need to be treated for 6 months or longer.
• If your kidneys are not working very well, your doctor may reduce the dose of Lamisil
Tablets you take.
• Swallow the tablets whole with a glass of water.
What if you forget to take a dose?
If you miss taking a Lamisil Tablet, do not worry. Take it as soon as you remember.
Take your next tablet at the usual time, then carry on as normal until you have finished all
the tablets. It is important that you finish all the tablets you have been given unless your
doctor tells you to stop taking them.
What if you take too many tablets?
All tablets can be risky if you take too many.
If you take too many Lamisil Tablets at once, tell your doctor or hospital casualty
department as soon as possible. Take your medicine pack with you so that people can see
what you have taken.

Lamisil Tablets are suitable for most people, but, like all medicines, they can sometimes
cause side effects. Any side effects are usually mild or moderate and don’t last for too long.
Some side effects can be serious
Stop taking the tablets and tell your doctor immediately if you notice any of the
following rare symptoms:
• Yellowing of your skin or eyes. Unusually dark urine or pale faeces, unexplained
persistent nausea, stomach problems, loss of appetite or unusual tiredness or weakness
(this may indicate liver problems), increase in liver enzymes which may be noted on a
blood test result
• Severe skin reactions including rash, light sensitivity, blistering or wheals
• Weakness, unusual bleeding, bruising, abnormal pale skin, unusual tiredness, or
weakness or breathlessness on exertion or frequent infections (this may be a sign of
blood disorders)
• Difficulty breathing, dizziness, swelling mainly of the face and throat, flushing, crampy
abdominal pain, stiffness, rash, fever or swollen/enlarged lymph nodes (possible signs of
severe allergic reactions)
• Symptoms such as rash, fever, itching, tiredness or if you notice appearance of purplish
spots under the skin surface (signs of blood vessel inflammation)
• Severe upper stomach pain which spreads to the back (possible signs of pancreas
• Unexplained muscle weakness or pain, or dark (red-brown) urine (possible signs of
muscle breakdown)
The most common side effects are:• Headache
• Stomach problems such as loss of appetite, ache, indigestion, feeling bloated or sick
• Diarrhoea
• Itching, rash or swelling
• Pains in the muscles and joints
The side effects listed below have also been reported.
Up to 1 in 100 people have experienced:
Taste loss and taste disturbance. This usually disappears within several weeks after you
stop taking the medicine. However, a very small number of people, (less than 1 in 10,000),
have reported that the taste disturbance lasts for some time and, as a result, they go off
their food and lose weight. There have also been reports of some people experiencing
anxiety or symptoms of depression as a result of these taste disturbances.
Up to 1 in 1,000 people have experienced:
• Feeling unwell, dizzy
• Numbness or tingling
Up to 1 in 10,000 people have experienced:
• Feeling tired
• Decrease in the number of some blood cells. You may notice that you seem to bleed or
bruise more easily than normal, or you may catch infections easily and these might be
more severe than usual
• Psoriasis like skin eruptions, or worsening of any psoriasis including a rash or eruption of
small pus containing blisters
• Vertigo
• Hair loss
• Onset or worsening of a condition called lupus (a long-term illness with symptoms
including skin rash and pain in the muscles and joints)
The following have also been reported:
Signs of blood disorders: weakness, unusual bleeding, bruising or frequent infections.
Disorders of sense of smell which may be permanent, impaired hearing, hissing and/or
ringing in the ears, flu like symptoms, increase in blood of a muscle enzyme called creatine
phosphokinase (may be found on a blood test), reduced or blurred vision.
If any of the symptoms become troublesome, or if you notice anything else not
mentioned here, please go and see your doctor. He/she may want to give you a
different medicine.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly via the
Yellow Card Scheme at: By reporting side effects, you can
provide more information on the safety of this medicine.
• Lamisil Tablets should be protected from light. Do not store above 25°C. Keep the tablets
in the foil, only remove them when it is time to take your medicine.
• Keep out of the sight and reach of children.
• Do not use after the expiry date printed on the carton label or blister strip. The expiry date
refers to the last day of that month.
• If your doctor tells you to stop taking Lamisil Tablets, please take any unused tablets
back to your pharmacist to be destroyed. Only keep the tablets if the doctor tells you to.
Do not throw them away with your normal household water or waste. This will help to
protect the environment.
• If the tablets become discoloured or show any other signs of deterioration, you should
seek the advice of your pharmacist before taking them.
Each tablet contains 250mg of the active ingredient terbinafine (as hydrochloride). The
tablets are round, biconvex off-white and coded LAMISIL 250 on one side with a breakline
on the reverse.
Lamisil Tablets also contain the following:
magnesium stearate, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, and
sodium starch glycollate.
Lamisil Tablets are available as blister packs of 14 or 28 tablets.
PL No: 15814/0055
This product is manufactured by Novartis Farmaceutica SA, Gran Via de les Corts
Catalanes, 764-08013 Barcelona, Spain and is procured from within the EU and
repackaged by the Product Licence holder: O.P.D. Laboratories Ltd., Unit 6 Colonial Way,
Watford, Herts WD24 4PR.
Leaflet revision and issue date (Ref.) 14.03.2017.
Trade Mark holder for Lamisil is Novartis AG, Basel, Switzerland.

To request a copy of this leaflet in Braille, large print or
audio please call 01923 332 796.

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.